CUBE vs SHPH · P/E 25, rev $1.07B vs $1.8M cap
CubeSmart (CUBE) versus Shuttle Pharmaceuticals Inc (SHPH) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Shuttle Pharmaceuticals Inc (SHPH) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
SHPH does not have a complete income-statement cache yet.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. SHPH currently screens at market cap $1.8M.
Not investment advice. Open the CUBE and SHPH stock pages for the full models.
Not investment advice.